Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Cost-per-QALY in the US and Britain
28 December 2015
Professor Weinstein compares the use of cost-per-QALY approaches in the UK and the US. Britain has got it closer to right, but may go a little…
OHE at ISOQOL 2015: Valuing Health-Related Quality of Life
8 December 2015
This post summarises OHE’s activities at the ISOQOL 22nd Annual Conference in Vancouver, October 2015.
OHE Lunchtime Seminar on 14 December 2015: From the Antipodes to the Motherland: Reflections on HTA Decision Makers as Budget Takers and Budget Makers
13 November 2015
OHE’s Deputy Director Paula Lorgelly will present an OHE Seminar on 14th December 2015 on the topic of HTA decision makers as budget takers and budget…
Valuing Health at the End of Life: A Review of the Empirical Literature
3 November 2015
Do members of the general public wish to place greater weight on a unit of health gain for end of life patients than on that for…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
28 October 2015
Multi-indication pricing (MIP) involves setting a different price for each major indication approved for a medicine. We explore the feasibility of implementing MIP in the UK.
Just Published: Testing the Feasibility of Obtaining EQ-5D-5L Values in the United Arab Emirates
23 October 2015
This study tests the feasibility of eliciting EQ-5D-5L values from a general public sample in the United Arab Emirates.
OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
20 October 2015
This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries,…
Recently Published: Local Health Care Expenditure Plans and their Opportunity Costs
8 September 2015
Recently published in Health Policy is an article by Sarah Karlsberg Schaffer, Jon Sussex, Nancy Devlin and Andrew Walker entitled “Local health care expenditure plans and…
Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations
25 August 2015
A Research Paper on the topic of incorporating life-cycle price modelling into pharmaceutical cost-effectiveness evaluations has just been published by OHE.